OMIC RSI Chart
Last 7 days
-7.3%
Last 30 days
-5%
Last 90 days
-30.9%
Trailing 12 Months
-52.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 9.6M | 0 | 0 | 0 |
2023 | 4.1M | 5.9M | 5.3M | 10.0M |
2022 | 758.0K | 773.0K | 1.8M | 3.4M |
2021 | 531.3K | 598.5K | 665.8K | 733.0K |
2020 | 0 | 0 | 0 | 464.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 15, 2024 | ropp sam | acquired | - | - | 4,187 | chief commercial officer |
Mar 15, 2024 | spaventa andrew | gifted | - | - | -14,583 | chief executive officer |
Mar 15, 2024 | spaventa andrew | acquired | - | - | 14,583 | chief executive officer |
Mar 15, 2024 | spaventa andrew | gifted | - | - | 14,583 | chief executive officer |
Mar 15, 2024 | glezer eli n. | acquired | - | - | 7,500 | chief scientific officer |
Mar 15, 2024 | meeter dalen | acquired | - | - | 6,250 | chief financial officer |
Dec 15, 2023 | meeter dalen | acquired | - | - | 6,250 | chief financial officer |
Dec 15, 2023 | glezer eli n. | acquired | - | - | 7,500 | chief scientific officer |
Dec 15, 2023 | spaventa andrew | gifted | - | - | 14,583 | chief executive officer |
Dec 15, 2023 | spaventa andrew | acquired | - | - | 14,583 | chief executive officer |
Which funds bought or sold OMIC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Engineers Gate Manager LP | unchanged | - | 814 | 7,734 | -% |
May 15, 2024 | Tikvah Management LLC | unchanged | - | 17,141 | 162,926 | 0.05% |
May 15, 2024 | Casdin Capital, LLC | unchanged | - | 71,623 | 680,742 | 0.05% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -12.87 | -83.00 | 3,061 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -5,778 | - | -% |
May 15, 2024 | ARCH Venture Management, LLC | unchanged | - | 205,522 | 1,953,410 | 2.43% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 49.33 | 36,272 | 90,499 | -% |
May 15, 2024 | PERCEPTIVE ADVISORS LLC | unchanged | - | 115,065 | 1,093,650 | 0.02% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | 6,573 | 62,475 | -% |
May 15, 2024 | ORBIMED ADVISORS LLC | unchanged | - | 29,251 | 278,026 | -% |
Unveiling Singular Genomics Systems, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Singular Genomics Systems, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Singular Genomics Systems, Inc. News
Income Statement (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Revenue | -93.0% | 442 | 6,357 | 462 | 2,295 | 863 | 1,672 | 1,115 | 428 | 156 | 105 | 84.00 | 413 | 131 | 104 | 76.00 | 156 |
Cost Of Revenue | -44.0% | 861 | 1,538 | 527 | 597 | 807 | 789 | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 8.3% | -419 | -457 | -65.00 | -92.00 | 56.00 | -24.00 | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 6.5% | 26,429 | 24,824 | 24,474 | 27,511 | 25,434 | 22,506 | 24,694 | 24,243 | 22,020 | 19,673 | 17,461 | 13,883 | 10,262 | - | 7,778 | 6,768 |
S&GA Expenses | 13.7% | 14,935 | 13,134 | 13,254 | 14,887 | 13,204 | 11,746 | 11,962 | 12,182 | 11,375 | 10,218 | 8,551 | 6,201 | 3,654 | - | 1,698 | 1,443 |
R&D Expenses | -1.7% | 11,494 | 11,690 | 11,220 | 12,624 | 12,230 | 10,761 | 12,732 | 12,061 | 10,645 | 9,455 | 8,910 | 7,682 | 6,608 | - | 6,080 | 5,325 |
Interest Expenses | -1.0% | 284 | 287 | 285 | 270 | 259 | 243 | 211 | 167 | 142 | 192 | 234 | 232 | 188 | - | 202 | 235 |
Net Income | -7.6% | -25,024 | -23,249 | -22,360 | -25,578 | -23,633 | -21,101 | -23,790 | -23,982 | -22,006 | -19,760 | -17,611 | -37,479 | -23,921 | -7,115 | -7,933 | -6,847 |
Net Income Margin | -5.9% | -10.07* | -9.50* | -17.51* | -15.83* | -22.68* | -26.96* | -49.63* | -107.84* | -127.78* | -134.75* | -129.37* | -127.73* | -86.24* | - | - | - |
Free Cashflow | -23.0% | -23,728 | -19,294 | -16,923 | -20,304 | -18,096 | -21,735 | -22,913 | -27,690 | -20,778 | -17,469 | -12,597 | -16,807 | -9,692 | - | - | - |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -9.9% | 239 | 265 | 285 | 284 | 305 | 328 | 345 | 366 | 342 | 356 | 371 | 384 | 31.00 |
Current Assets | -13.4% | 166 | 192 | 211 | 226 | 246 | 268 | 286 | 306 | 326 | 348 | 364 | 379 | 28.00 |
Cash Equivalents | 52.2% | 25.00 | 16.00 | 33.00 | 75.00 | 129 | 74.00 | 95.00 | 155 | 190 | 202 | 240 | 258 | 12.00 |
Inventory | -3.6% | 13.00 | 14.00 | 13.00 | 14.00 | 17.00 | 18.00 | 17.00 | 12.00 | 6.00 | 3.00 | - | - | - |
Net PPE | 1.2% | 14.00 | 14.00 | 13.00 | 11.00 | 11.00 | 11.00 | 10.00 | 9.00 | 7.00 | 6.00 | 5.00 | 3.00 | 2.00 |
Liabilities | -4.7% | 82.00 | 86.00 | 85.00 | 66.00 | 65.00 | 68.00 | 69.00 | 69.00 | 25.00 | 19.00 | 19.00 | 17.00 | 13.00 |
Current Liabilities | -12.1% | 16.00 | 18.00 | 15.00 | 14.00 | 12.00 | 14.00 | 14.00 | 13.00 | 9.00 | 7.00 | 6.00 | 8.00 | 4.00 |
Long Term Debt | -14.3% | 8.00 | 9.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 6.00 | 8.00 |
LT Debt, Current | 100.1% | 3.00 | 1.00 | - | - | - | - | - | - | - | - | - | 3.00 | 1.00 |
LT Debt, Non Current | -100.0% | - | 9.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 6.00 | 8.00 |
Shareholder's Equity | -12.5% | 157 | 179 | 199 | 218 | 240 | 260 | 277 | 298 | 317 | 336 | 352 | 367 | - |
Retained Earnings | -7.4% | -362 | -337 | -314 | -292 | -266 | -242 | -221 | -197 | -173 | -151 | -132 | -114 | -53.12 |
Additional Paid-In Capital | 0.6% | 519 | 516 | 514 | 511 | 507 | 504 | 500 | 496 | 492 | 488 | 484 | 481 | 2.00 |
Shares Outstanding | 0.3% | 74.00 | 74.00 | 73.00 | 73.00 | 72.00 | 72.00 | 71.00 | 71.00 | 71.00 | 72.00 | 39.00 | 22.00 | - |
Float | - | - | - | - | 49.00 | - | - | - | 214 | - | - | - | 1,300 | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | -25.4% | -23,703 | -18,902 | -16,813 | -19,998 | -17,934 | -19,917 | -21,786 | -25,552 | -19,839 | -15,699 | -10,976 | -15,841 | -9,185 | - | - | - |
Share Based Compensation | 7.8% | 2,896 | 2,687 | 2,794 | 2,842 | 3,081 | 3,099 | 3,399 | 3,605 | 3,566 | 2,935 | 2,859 | 2,341 | 1,096 | - | - | - |
Cashflow From Investing | 4750.8% | 31,579 | 651 | -24,703 | -35,086 | 72,945 | 171 | -38,117 | -10,006 | 8,386 | -23,325 | -5,709 | -11,366 | -90,461 | - | - | - |
Cashflow From Financing | -100.0% | - | 72.00 | - | 618 | 6.00 | 750 | 27.00 | 101 | 23.00 | 810 | -1,320 | 239,154 | 133,484 | - | - | - |
Buy Backs | -100.0% | - | 6.00 | - | 6.00 | 7.00 | -35.00 | 53.00 | 421 | 11.00 | - | - | - | - | - | - | - |
Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 442 | $ 863 |
Cost of revenue | 861 | 807 |
Gross margin | (419) | 56 |
Operating expenses: | ||
Research and development | 11,494 | 12,230 |
Selling, general and administrative | 14,935 | 13,204 |
Total operating expenses | 26,429 | 25,434 |
Loss from operations | (26,848) | (25,378) |
Other income (expense): | ||
Interest income | 2,108 | 2,004 |
Interest expense | (284) | (259) |
Total other income | 1,824 | 1,745 |
Net loss | $ (25,024) | $ (23,633) |
Basic and diluted net loss per share, Basic | $ (0.34) | $ (0.33) |
Basic and diluted net loss per share, Diluted | $ (0.34) | $ (0.33) |
Weighted Average Number of Shares Outstanding, Basic | 73,925,966 | 71,926,412 |
Weighted Average Number of Shares Outstanding, Diluted | 73,925,966 | 71,926,412 |
Condensed Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 24,109 | $ 16,233 |
Short-term investments | 126,629 | 157,708 |
Accounts receivable | 137 | 565 |
Inventory, net | 13,081 | 13,572 |
Prepaid expenses and other current assets | 2,519 | 4,150 |
Total current assets | 166,475 | 192,228 |
Right-of-use lease assets | 57,094 | 57,797 |
Property and equipment, net | 13,854 | 13,692 |
Restricted cash | 600 | 600 |
Other noncurrent assets | 1,078 | 1,150 |
Total assets | 239,101 | 265,467 |
Current liabilities: | ||
Accounts payable | 2,012 | 2,587 |
Accrued expenses | 3,265 | 6,079 |
Lease liabilities, current | 7,822 | 7,764 |
Other current liabilities | 2,980 | 1,857 |
Total current liabilities | 16,079 | 18,287 |
Lease liabilities, non current | 58,092 | 58,623 |
Long-term debt, net of issuance costs | 7,627 | 8,901 |
Other noncurrent liabilities | 605 | 650 |
Total liabilities | 82,403 | 86,461 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity: | ||
Common stock, $0.0001 par value; 400,000,000 shares authorized, 74,067,366 and 73,823,161 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 7 | 7 |
Additional paid-in capital | 519,361 | 516,439 |
Accumulated other comprehensive gain (loss) | (51) | 155 |
Accumulated deficit | (362,619) | (337,595) |
Total stockholders' equity | 156,698 | 179,006 |
Total liabilities and stockholders' equity | 239,101 | 265,467 |
Series A Common Stock Equivalent Convertible Preferred Stock [Member] | ||
Stockholders' equity: | ||
Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 shares issued and outstanding at March 31, 2024 and December 31, 2023 | $ 0 | $ 0 |